New Market Research Report on Life Cycle Management – Strategies & Optimizing revenues and defending generic competition 2017

Recent research and the current scenario as well as future market potential of “Life Cycle Management Strategies – Optimizing revenues and defending generic competition” globally.

GBI Research’s latest report, “”Life Cycle Management Strategies Optimizing revenues and defending generic competition”” discusses various stages of product lifecycle management (LCM), Developmental, commercial and legal LCM strategies, objectives, benefits, factors impacting the choice of lifecycle management strategies, and keys to successful implementation of the strategies. The report provides detailed case studies for each of the key strategies such as indication expansion, reformulation, fixed-dose combinations, pricing strategies and so on.

Companies mentioned in the report are AbbVie, Actavis, AstraZeneca, Cipla, Gilead, GlaxoSmithKline, Gleevec, Janssen, MannKind, Merck, Novartis, Orexo, Otsuka, Pfizer, Roche, Salix Pharmaceuticals, Sanofi-Aventis, Solvay, Teva and Vifor Pharma.


    Introduction of LCM and product life cycle
    Objectives of LCM and factors impacting the choice of strategies
    LCM strategies depending on the way of approach
    Impact of LCM strategies on sales and growth trend of selected products
    Patent term extension and market exclusivity in the US and Europe
    LCM strategies of pipeline drugs of key players
    Keys to successful implementation of LCM strategies

Get PDF for more Professional and Technical insights @

Reasons to buy

    Identify the key LCM strategies used by most of the pharmaceutical companies
    Analyze the strategies to increase lifecycle and revenues of a drug
    Gain an understanding on the implementation of multiple strategies for a single product by including case studies
    Understand the operational pipeline strategies of key players

Executive Summary

Overview of Product Life Cycle
Product Life Cycle Curve
Objectives of Life Cycle Management (LCM)
Classification and Benefits of LCM Strategies
Strategic Planning for LCM
Factors Impacting Choice of LCM Strategies
Developmental Strategies

Make an Enquiry about TOC @

Indication Expansion/Sequencing and Repositioning
Patient Subpopulations and Personalized Medicine
New Dosage Forms
New Route of Administration
Special Cases
New Dosage Strengths and Regimen
Fixed-Dose Combination and Co-packaging
Next Generation Products and Modified Chemistry
Chiral Switching
Multiple Developmental Strategy Approach
Commercial Strategies
Rx-to-OTC/BTC Switch
Geographical Expansion
Pricing Strategy and Tactics
Pricing Strategy for Targeting Multiple Indications

Browse Report @

Co-pay Cards
Awareness, Brand Loyalty and Service Programs
Regulatory and Legal Strategies
Authorized Generics
Legal Defense and Pay for Delay
Citizen’s Petition
Patent Term Extension and Market Exclusivity
The Pharmaceutical Pipeline and LCM
Successful Implementation of LCM Strategies

Media Contact
Company Name: Researchmoz Global Pvt. Ltd.
Contact Person: Rohit Bhisey
Phone: +15186212074
Address:90 State Street
City: Albany
State: New York 12207
Country: United States